Basic info
Industry
pharmaceuticals
Sectors
melflufen
RRMM
peptide-drug conjugate
Plasma Cell Myeloma
Relapsed & Relapsed-Refractory Multiple Myeloma
efficacy studies
oncology
phase 3
peptidase targeting
phase 1
phase 2
anti-angiogenic
OPD5
peptide conjugated alkylator
alkylation
EMD
melphalan flufenamide
cytotoxicity
Orphan Drug
Multiple Myeloma
Date founded
2000